Diagnostyka SA’s shares surged in the Polish laboratory operator’s Warsaw debut, signaling a solid start for one of Europe’s ...

RenovoRx Inc. (RNXT) announced the pricing of a firm commitment, underwritten public offering of about 11.52 million shares of its ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...

(NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expects to grant the underwriter ...

Volcon, Inc. (Nasdaq:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced the closing of its previously announced firm commitment underwritten public offering.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted range, the cement producer said on Thursday.

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

MALVERN, Pa. - Neuronetics , Inc. (NASDAQ: NASDAQ:STIM), a global leader in neuroscience with a market capitalization of $197 million, has launched an underwritten public offering of its common stock, ...

Market insiders say entrepreneurs are losing interest in raising funds through initial public offerings (IPOs), while the prolonged absence of new company listings has further dampened investor enthus ...

MOUNTAIN VIEW, Calif. - RenovoRx , Inc. (NASDAQ:RNXT), a $35.7 million market cap developer of targeted oncology therapies, has initiated an underwritten public offering of its common stock and ...